Purpose: To study the technical difficulties using the MONARCH II injector, intraoperative incidents, postoperative astigmatism.
Methods: Retrospective study which included 135 eyes with cataract who underwent cataract surgery between March 2002-August 2003. The surgical intervention consisted of lens extraction by phacoemulsification technique and IOL implantation with the MONARCH II injector. We recorded the following parameters: problems during the loading of the IOL in the cartridge, difficulties during the implant, problems due to the damage of the IOL during the passage in the cartridge, IOL centration in the capsular bag, induced postoperative astigmatism.
Results: We had no major difficulties using this type of injector. We did not recorded important differences between the hydrophobic and hydrophilic IOLs. We had a number of 17 intraoperative incidents (12.6%). We met the following intraoperative incidents: the last haptic capture in the tunnel of the cartridge in 5 cases (3.7%), small marks on the optic surface left by the tip of the injector in 3 cases (2.2%), the leading haptic stuck on the optic surface in 2 cases (1.4%), breaking of the last haptic (multi-piece IOL) in 1 case (0.7%), the turning up side down of IOL during unfolding (hydrophilic IOLs) in 6 cases (4.4%). Postoperative astigmatism was less than 1D cylinder in 88% of cases.
Conclusions: The IOL implantation using MONARCH II injector is easy and doesn't need learning curve. The technique is superior compared with forceps implantation (especially for acrylic hydrophilic IOLs). No significant differences between implantation of acrylic IOLs. IOL centration was good. The design of the injector tip preserved optic surface and haptic from damage. The conical tip of the cartridge didn't change the architecture of the corneal wound. The postoperative astigmatism was small.
Download full-text PDF |
Source |
---|
J Ophthalmol
January 2025
Optics and Optometry Department, Universidad Complutense de Madrid, Madrid, Spain.
To analyze the refractive accuracy of a novel swept-source optical coherence biometer (SS-OCT), that uses individual refractive indices to measure axial length, in short and long eyes implanted with monofocal intraocular lenses (IOLs). This retrospective comparative study considered eyes with short axial length (AL) (< 22.5 mm) or long AL (> 26 mm) bilaterally implanted with the Acrysof IQ monofocal IOL.
View Article and Find Full Text PDFClin Ophthalmol
January 2025
Sengi, Penniac, NB, Canada.
Purpose: To evaluate visual outcomes and quality of vision following bilateral implantation of a hydrophobic acrylic intraocular lens (IOL) in eyes targeted for emmetropia.
Methods: This was a prospective, single arm study. Subjects were bilaterally implanted with the Clareon PanOptix IOL and evaluated at 1 and 3 months postoperatively.
J AAPOS
January 2025
Johns Hopkins University Wilmer Eye Institute, Baltimore, Maryland. Electronic address:
Background Recommendations regarding long-term postoperative activity are intended to prevent adverse events, but no common policy or best practice exists among ophthalmologists for pediatric patients. We surveyed ophthalmologists on their postoperative guidelines after the one-month postoperative period following childhood cataract and glaucoma surgeries. Methods A 28-question anonymous Qualtrics survey was distributed via listservs and social media.
View Article and Find Full Text PDFLife (Basel)
January 2025
Centro Oftalmológico Charles, Buenos Aiers C1116, Argentina.
Background: The aim of this study was to evaluate visual outcomes and patient satisfaction after bilateral implantation of a new hydrophobic acrylic intraocular lens called Clareon (Alcon) using the mini-monovision technique.
Methods: A single-center, prospective, nonrandomized study was conducted in Tandil (Buenos Aires, Argentina), including patients scheduled for cataract surgery. To achieve mini-monovision, the spherical equivalent was calculated between -0.
Biomedicines
January 2025
Department of Ophthalmology, UHC Sestre Milosrdnice, 10000 Zagreb, Croatia.
We describe a novel experimental device, the VaMa (Vatavuk and Marić) artificial intraocular lens (IOL) capsule, and a method that enables all IOL types to be implanted in the bag. We present the application of the device and the procedure in patients with aphakia and native capsule damage and without efficient capsular support. The VaMa device and the method facilitate IOL exchange due to refractive errors and, in the case of their invention, the implementation of superior IOLs in the future.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!